Brussels - Solvay will build a new manufacturing and filling facility in the Netherlands to produce Hydrogen Peroxide grades that are used as disinfection and decontamination agents to meet growing demand from the pharmaceutical industry.

The new facility at Solvay’s Peroxide production site in Linne-Herten, in the southern part of the Netherlands, is due to be completed in July 2015 and is part of Solvay’s Global Business Unit Peroxides ambition to bolster growth in high value-added specialties.

With this investment, Solvay responds to the increased need in the pharmaceutical sector for its INTEROX®PH grades when used as Active Pharma Ingredients(API), and INTEROX®SG grades when used as decontamination agent in this industry.

Demand growth is driven by the European Union’s Falsified Medicines Directive, a legal framework to ensure the safe production and use of medicines.

The grades are produced in compliance with Good Manufacturing Process (GMP) conditions, the standard of quality assurance applied by the Pharma Industry. The Dutch health inspection pro-vides GMP certification.

The site in Linne-Herten already manufactures Solvay’s main Peroxides disinfection grades for the European market, for both peracetic acid and hydrogen peroxide. It has in-depth knowledge in the complex production of purified grades, filling, packaging and labelling operations ranging from bulk deliveries to packs of 1 liter bottles.

SOLVAY PEROXIDES Business Unit is a worldwide market and technology leader in Hydrogen Peroxide. Providing functional qualities such as bleaching, oxidation or disinfection, it delivers products and services to the pulp, chemicals, aquaculture, food, mining, waste water treatment, homecare and textile industries. SOLVAY PEROXIDES operates 17 plants in North and South America, Europe & Middle East, Asia and Australia. It operates the biggest Hydrogen Peroxide plant in the world and is developing in parallel a new small satellite plant concept, myH2O2, designed for installation at customer’s sites.